Back to Rankings

BIAF

bioAffinityA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
BIAF vs peer average
95/100
BIAF vs. peer average (A vs. D)
Grade spread
B 1 · C 1 · D 4 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ACXP is the first available peer comparator.

A same-sector micro-cap biotech comparator for financing and event-risk context only; it is not a direct operating peer for a diagnostics commercialization model.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerACXPAcurx
BIAF
bioAffinity
ACXP
Acurx
Grade
A
F
Momentum
100
31
Value
41
41
Sentiment
48
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ACXP

BIAF / ACXP
Grade Position
Above peers
BIAF vs. peer average (A vs. D)
95/100
Momentum
100
BIAF
Value
41
BIAF
Sentiment
48
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BIAF
1
ACXP
ACXP
F
20/100
+4
2
CDIO
CDIO
B
80/100
+1
3
CYCN
CYCN
D
40/100
+3
4
GNPX
Genprex Inc Common
D
40/100
+3
5
LIMN
Liminatus Pharma Inc Class A Common
F
20/100
+4
ACXP is the first peer returned for this comparison set.